The Union government is yet to provide the funding, staff and infrastructure to commission the 18 Centres for Pharmacovigilance at government medical college hospitals in Karnataka.
Pharmacovigilance prevents adverse drug reactions. The Centres will monitor and evaluate the information from hospitals on Adverse Drug Reactions (ADRs) besides identifying information on drug hazards to ensure the safety of patients.
In early 2010, following the need to open up pharmacovigilance across the country, the erstwhile Drugs Control General of India (DCGI) Dr Surinder Singh was working to approve the Centre for Pharmacovigilance at government hospitals attached to the medical colleges.
This led the Karnataka health and family welfare department to identify 16 locations which covers 12 government medical colleges hospitals and six government independent hospitals to establish the Centre for Pharmacovigilance. The state had also sent a letter of intent to these institutions.
The 12 colleges from the 10 districts are Bangalore Medical College and Research Institute, Government Dental College and Hospital, Bangalore, Mysore Medical College and Research Institute (MMC&RI), Bellary Medical College now renamed as Vijayanagara Institute of Medical Sciences, Government Dental College and Research Institute, Bellary, Mandya Institute of Medical Sciences, Karnataka Institute of Medical Sciences, Hubli which is attached to the Kempegowda Institute of Medical Sciences, Belgaum Institute of Medical Sciences (BIMS), Shimoga Institute of Medical Sciences(SIMS), Bidar Institute of Medical Sciences(BRIMS), Raichur Institute of Medical Sciences(RIMS), Hassan Institute of Medical Sciences (HIMS). The four hospitals are Jayadeva Institute of Cardiology, Indira Gandhi Institute of Child Health, Kidwai Memorial Institute of Oncology, Rajiv Gandhi Institute of Chest Diseases and SDS Sanatorium, Karnataka Institute of Diabetology, Karnataka Institute of Nephrology.
In fact in 2004, the Director General Health Services (DGHS), Ministry of Health and Family Welfare received grant from the World Bank to start a National Pharmacovigilance Programme for which Central Drugs Standard Control Organization (CDSCO) was the coordinator. Under the programme, 21 pharmacovigilance centres were opened with two zonal centres While All India Institute of Medical Sciences, New Delhi covered North and East, the KEM Hospital at Mumbai monitored southern and western regions in the country. There were five regional pharmacovigilance centres at Kolkata, Pondicherry (JIPMER), Nagpur and Mumbai with two centres. There were several periphery centres including Bangalore at the Victoria Hospital, Goa, and Mysore within JSS College of Pharmacy.
There are already a couple of similar centres run by pharmacy colleges in Karnataka which include the Drug Information Centre at Victoria Hospital supported by the Al Ameen College of Pharmacy.
“Since pharmacovigilance is now viewed as a critical component in patient care, we had proposed to the DCGI on the need to set-up centres across healthcare providers in the state,” stated Dr BR Jagashetty, Karnataka drugs controller.
With India now recognized as a hub for human drug studies, an efficient pharmacovigilance programme is a must as stringent safety pharmacology studies also help to prevent fatality and serious injuries of volunteers and patients who are part of the clinical trials, he added.
Source: PB
by
Akshaya Srikanth
Pharm.D Intern
Hyderabad, India
Tidak ada komentar:
Posting Komentar